{"name": "Charles River Laboratories International",
 "permalink": "charles-river-laboratories-international",
 "crunchbase_url": "http://www.crunchbase.com/company/charles-river-laboratories-international",
 "homepage_url": "http://www.criver.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1947,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "781-222-6000",
 "description": "",
 "created_at": "Fri Sep 11 15:38:32 UTC 2009",
 "updated_at": "Thu Aug 30 02:29:22 UTC 2012",
 "overview": "\u003Cp\u003ECharles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0005/9479/59479v1-max-150x150.png"],
     [[189,
       56],
      "assets/images/resized/0005/9479/59479v1-max-250x250.png"],
     [[189,
       56],
      "assets/images/resized/0005/9479/59479v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "James",
      "last_name": "C. Foster",
      "permalink": "james-c-foster",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Thomas",
      "last_name": "F. Ackerman",
      "permalink": "thomas-f-ackerman",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$34M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://www.masshightech.com/stories/2011/09/26/daily45-Gene-mod-mice-project-lands-34M-for-Charles-River-Labs.html",
    "source_description": "Gene mod mice project lands $34M for Charles River Labs",
    "raised_amount": 34000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "National Institutes of Health",
         "permalink": "national-institutes-of-health",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0025/4340/254340v1-max-150x150.png"],
             [[250,
               38],
              "assets/images/resized/0025/4340/254340v1-max-250x250.png"],
             [[391,
               60],
              "assets/images/resized/0025/4340/254340v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 12400000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "Cap Funding Report",
    "acquired_year": 2008,
    "acquired_month": 9,
    "acquired_day": 15,
    "company":
     {"name": "Molecular Therapeutics",
      "permalink": "molecular-therapeutics",
      "image":
       {"available_sizes":
         [[[150,
            103],
           "assets/images/resized/0005/9477/59477v1-max-150x150.png"],
          [[250,
            172],
           "assets/images/resized/0005/9477/59477v1-max-250x250.png"],
          [[253,
            175],
           "assets/images/resized/0005/9477/59477v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": 24000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "",
    "acquired_year": 2009,
    "acquired_month": 8,
    "acquired_day": 1,
    "company":
     {"name": "Systems Pathology Company",
      "permalink": "systems-pathology-company",
      "image":
       {"available_sizes":
         [[[150,
            58],
           "assets/images/resized/0006/2942/62942v1-max-150x150.png"],
          [[208,
            81],
           "assets/images/resized/0006/2942/62942v1-max-250x250.png"],
          [[208,
            81],
           "assets/images/resized/0006/2942/62942v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.masshightech.com/stories/2012/08/27/daily34-Charles-River-Labs-acquires-Accugenix.html",
    "source_description": "Charles River Labs acquires Accugenix",
    "acquired_year": 2012,
    "acquired_month": 8,
    "acquired_day": 29,
    "company":
     {"name": "Accugenix",
      "permalink": "accugenix",
      "image":
       {"available_sizes":
         [[[150,
            34],
           "assets/images/resized/0020/8823/208823v1-max-150x150.png"],
          [[250,
            57],
           "assets/images/resized/0020/8823/208823v1-max-250x250.png"],
          [[271,
            62],
           "assets/images/resized/0020/8823/208823v1-max-450x450.png"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "251 Ballardvale Street",
    "address2": "",
    "zip_code": "01887",
    "city": "Wilmington",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.5890219,
    "longitude": -71.1574693}],
 "milestones":
  [{"description": "Charles River Laboratories International has inked leases for 85,000 square feet in Wilmington",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 25,
    "source_url": "http://www.masshightech.com/stories/2010/10/25/daily10-Charles-River-Labs-expands-in-Wilmington.html",
    "source_text": null,
    "source_description": "Charles River Labs expands in Wilmington",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Charles River Laboratories International",
      "permalink": "charles-river-laboratories-international"}},
   {"description": "Charles River Labs begins $150M stock buyback",
    "stoned_year": 2011,
    "stoned_month": 2,
    "stoned_day": 24,
    "source_url": "http://www.masshightech.com/stories/2011/02/21/daily34-Charles-River-Labs-begins-150M-stock-buyback.html",
    "source_text": "",
    "source_description": "Charles River Labs begins $150M stock buyback",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Charles River Laboratories International",
      "permalink": "charles-river-laboratories-international"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  [{"external_url": "http://jobs.criver.com",
    "title": "Charles River Laboratories Careers"}]}